NCT00006362View on ClinicalTrials.gov

PS-341 in Treating Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 1999

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions
LeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmPrecancerous ConditionUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

bortezomib

Trial Locations (2)

55905

Mayo Clinic, Rochester

53792-6164

University of Wisconsin Comprehensive Cancer Center, Madison

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER